Copyright
©The Author(s) 2018.
World J Hepatol. Jul 27, 2018; 10(7): 479-484
Published online Jul 27, 2018. doi: 10.4254/wjh.v10.i7.479
Published online Jul 27, 2018. doi: 10.4254/wjh.v10.i7.479
n | Disease | Previous LR(open:lap) | Procedure | Bleeding(mL) | Operating time (min) | Conversion(n) | Postoperative hospital stay (d) | Morbidity | Mortality | Ref. |
12 | HCC | 4:8 | LLS (n = 5), Pt (n = 4), Seg (n = 3) | 297 ± 134 272.2 ± 120 | 114.4 ± 11.0 63.9 ± 13.3 | 1 | 7.4 ± 2.5 6.2 ± 3.0 | 26.60% | 0% | [20] |
2 | Met | ND | ND | ND | ND | ND | ND | ND | ND | [21] |
6 | HCC | 3:3 (Lap RFA, n = 2) | LLS (n = 2), Pt (n = 4) | 283.3 ± 256.3 | 140.8 ± 35.7 | 0 | 5.67 ± 1.63 | 16.7% | 0% | [24] |
76 | Met (n = 63), HCC (n = 3), others (n = 10) | 28:44 | LLS (n = 4), Pt, seg (n = 53), above-seg (n = 19) | 300 (0–5000) | 180 (80–570) | 8 | 6 (2–42) | 26% | 0% | [23] |
4 | HCC (n = 3), Met (n =1) | 0:4 | LLS (n = 1), Pt (n = 3) | 481.7 ± 449.5 | 312.3 ± 158.4 | 1 | 10.6 ± 7.4 | 23.4% | 0% | [22] |
3 | HCC | 0:3 | ND | 281.3 (mean) | 264.6 (mean) | 0 | 8.6 (mean) | 0% | [26] | |
17 | ND | ND | ND | ND | ND | ND | ND | ND | ND | [25] |
20 | HCC | 15:5 | Pt | 78 (1–1500) | 239 (69–658) | 2 (HALS) | 9 (5–22) | 5% | 0% | [27] |
20 | HCC (n = 2), Met (n = 16), others (n = 2) | 0:20 | Minor (n = 14), major (n = 6) | 400 (IQR 150-200 mL) | 285 (IQR 195-360) | 3 | 4 (1-57) | 10% | 0% | [30] |
12 | HCC (n = 8), Met (n = 2), others (n = 2) | 8:4 | Pt (n = 9), Subseg (n = 3) | 50 (NC–840) | 301 (104–570) | 0 | 12 (9–30) | 0% | 0% | [29] |
11 | HCC | 6:5 | LLS = 2 Subseg = 9 | 100 (50-500) | 200 (131-352) | 0 | 6 (3-17) | 18.2% | 0% | [33] |
27 | Met | ND | Major = 25 Minor = 2 | ND (4 patients received transfusion) | 252.5 (180-300) | 1 | 9 (IQR 8-18) | 48.1% | 0% | [32] |
8 | HCC | 6:2 | Sec = 2 Seg = 2 Subseg = 4 | 200 (30-5000) | 343 (120-530) | 1 | 3.5 (3-8) | 12.5% | 0% | [31] |
20 | HCC (n = 15) Met (n = 5) | 12:8 | Anatomical = 1 Non-anatomical = 19 | 159 +/- 256 | 225 +/- 85 | 1 | 14.2 +/- 5.4 | 0% | 0% | [19] |
33 | HCC and combined (n = 18) Met (n = 15) | 21:12 | Anatomical = 11 Non-anatomical = 22 | 30 (NC-1012) | 217 (43-356) | 0 | 6.5 (3-47) | 6.1% | 3% | [18] |
Present status |
There are 16 reports of small series. Controversy still exists in the indication of repeat LLR |
These studies generally reported that it has better short-term outcomes without compromising the long-term outcomes (similar or longer operation time, reduces bleedings, reduced blood transfusion rate, less or similar morbidity and shorter hospital stay) |
It facilitates more meticulous dissection of adhesions strained by the pneumoperitoneum using magnified laparoscopic view |
Complete adhesiolysis can be avoided when the adhesion does not affect the current operative procedure |
Operation time was shorter and the adhesiolysis was easier for the patients previously treated with LLR than open LR |
It requires smaller (than open) working space between adhesions (this fact allows for minimal adhesiolysis, and operation time and bleeding amount were similar in primary and repeat LLR, although those from open LR are longer and increased) |
Future perspectives |
Further evaluations of anatomical resection or resections exposing major vessels after previous anatomical resection are needed |
One of the possible advantages for minor repeat LR of CLD liver is that the deterioration of liver function can be minimized |
It could prolong the overall survival of the HCC patients with CLD as a powerful local therapy which can be applied repeatedly with minimal deterioration of liver function |
- Citation: Morise Z. Status and perspective of laparoscopic repeat liver resection. World J Hepatol 2018; 10(7): 479-484
- URL: https://www.wjgnet.com/1948-5182/full/v10/i7/479.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i7.479